ADVFN US – Market Content Editor
-
U.S. Building Permits Dip Slightly, Outperforming Weak Forecasts
U.S. building permits fell modestly in the latest report, registering a -2.3% change, slightly improving on economists’ dismal forecast of -3.7%. While the decline indicates some cooling in the construction sector, the numbers suggest the contraction is less severe than anticipated. Building permits, which reflect upcoming construction activity including financing, employment, and regulatory approvals, are…
-
uniQure Shares Skyrocket After Positive Huntington’s Disease Gene Therapy Data
uniQure N.V. (NASDAQ:QURE) stock surged 150% Wednesday following the announcement of encouraging topline results from its pivotal Phase I/II study of AMT-130 in patients with Huntington’s disease, showing substantial slowing of disease progression compared to controls. The trial successfully hit its primary endpoint, with high-dose AMT-130 demonstrating a 75% reduction in disease progression at 36…
-
Soleno Therapeutics Shares Surge After Competitor’s Prader-Willi Treatment Misses Endpoint
Soleno Therapeutics (NASDAQ:SLNO) saw its stock climb 14% following news that Acadia Pharmaceuticals’ (NASDAQ:ACAD) Phase 3 trial for a Prader-Willi syndrome therapy failed to meet its primary endpoint. The COMPASS PWS trial from Acadia, which tested intranasal carbetocin (ACP-101) for hyperphagia in Prader-Willi syndrome, showed no statistically significant difference from placebo across secondary measures. As…
-
SAP Shares Climb Following OpenAI Partnership Targeting German Public Sector
SAP SE (NYSE:SAP) shares rose 2% after the software giant announced a strategic partnership with OpenAI to deliver a sovereign AI solution for Germany’s public sector. The initiative, named “OpenAI for Germany,” will leverage SAP’s enterprise software capabilities alongside OpenAI’s artificial intelligence technology to serve government institutions. The service will be powered by SAP subsidiary…
-
Freeport-McMoRan Shares Drop Following Fatal Mine Incident and Production Adjustments
Shares of Freeport-McMoRan Inc. (NYSE:FCX) tumbled 7% in pre-market trading Wednesday after the company confirmed that two workers were found dead at its Grasberg Block Cave mine in Indonesia, with five others still unaccounted for following a severe mud rush. The copper and gold mining giant reported that on September 20, two employees were discovered…
-
Terra Innovatum Accelerates NRC Licensing Path for SOLO™ Micro-Modular Reactor
Terra Innovatum Srl, a developer of micro-modular nuclear reactors, and GSR III Acquisition Corp. (NASDAQ:GSRT) announced accelerated progress in the U.S. Nuclear Regulatory Commission (NRC) licensing process for its SOLO™ reactor, marking key milestones in 2025 aimed at streamlining commercial deployment. Since the start of the year, Terra Innovatum has submitted several critical regulatory documents…
-
Dow Jones, S&P, Nasdaq, Futures, Wall Street May See Early Upside as AI Optimism Persists
U.S. stock futures point to a modestly higher open on Wednesday, suggesting that equities could rebound after yesterday’s broad sell-off. Investor confidence in the AI sector remains strong, continuing to drive market gains and record highs. Shares of Nvidia (NASDAQ:NVDA) are showing early gains, rising 0.4% in pre-market trading after falling 2.8% on Tuesday. The…
-
Acadia Healthcare Shares Jump on Activist Investor Stake Report
Shares of Acadia Healthcare Company (NASDAQ:ACHC) rose 5% on Wednesday after the Financial Times reported that activist investor Engine Capital has acquired a stake in the mental health services provider. The report indicates that Engine Capital now holds roughly 3% of Acadia’s shares and is advocating for major corporate changes amid ongoing federal investigations. In…
-
Acadia Pharmaceuticals Shares Drop After Phase 3 PWS Trial Misses Primary Goal
Shares of Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) fell 13% on Wednesday following the announcement that its Phase 3 COMPASS trial for Prader-Willi syndrome (PWS) did not meet the primary endpoint. The study tested intranasal carbetocin (ACP-101) for hyperphagia in PWS patients. The trial did not show a statistically significant improvement over placebo on the Hyperphagia Questionnaire…
-
Uranium Energy Posts Lower-Than-Expected Fiscal Revenue, Shares Tick Up
Uranium Energy Corp (AMEX:UEC) reported fiscal 2025 revenue of $66.84 million on Wednesday, falling short of analyst expectations of $77.2 million, while registering a loss of -$0.20 per share versus the consensus estimate of -$0.18. Despite the revenue miss, the company’s shares rose 1.66% in pre-market trading. The producer sold 810,000 pounds of uranium in…